Canavan disease

Definition

The ASPA gene encodes aspartoacylase, the enzyme that breaks down N-acetyl-L-aspartic acid (NAA) in neurons; deficiency leads to accumulation of NAA and disrupts myelin formation. In the severe infantile form, developmental delay, hypotonia, macrocephaly and seizures appear at 3 to 5 months of age; the juvenile form presents with delayed speech/motor development.

Gene/region examined

ASPA - Exon 1, ASPA - Exon 2, ASPA - Exon 3, ASPA - Exon 4, ASPA - Exon 5, ASPA - Exon 6

Method

Sequence analysis

Accepted sample types

EDTA blood, AF, CVS

Inheritance

Hereditary, autosomal recessive; particularly common in the Ashkenazi Jewish population.

Related Tests